Executive Series 27 Jul 16: Viralytics Ltd (VLA) Managing Director, Malcolm McColl
In this short video we discuss: · How trends in cancer treatment are changing from chemo & radiation treatment to methods focussing on the patient’s immune system; · How VLA is using the common cold to help develop cancer treatments; · The strategy VLA intends to apply when commercialising its technology; · Factors that have attracted investors to VLA, resulting in the group becoming a large cap bio-tech by Australian standards; · The VLA roadmap over the course of the next 6 to 12 months. For more videos in the series visit : (VIEW LINK)
CommSec is Australia's leading online broker. CommSec has been committed to providing the best in online trading since 1995. CommSec helps make informed investment decisions with comprehensive market research, free live pricing and powerful...
No areas of expertise